Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus

World Journal of Gastroenterology

Volumn 12, Issue 23, 2006, Pages 3746-3750

  Gockel, Ines ^a   Dirksen, Kathrin ^a   Messow, Claudia M ^a   Junginger, Theodor ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Adenocarcinoma; Long term prognosis; Oesophagus; Perioperative course; Preoperative C reactive protein; Squamous cell carcinoma

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD TRANSFUSION; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NORMAL VALUE; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME;

EID: 33745475012     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i23.3746     Document Type: Article

References (29)

1. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001; 182:197-201
2. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998; 176: 335-338
3. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Aoki T, Sugaya M, Miyazawa Y, Hayashi H, Miyazaki S, Ochiai T. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma, J Surg Oncol 2003; 83: 248-252
4. Nozoe T, Korenaga D, Futatsugi M, Saeki H, Maehara Y, Sugimachi K. Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker. Cancer Lett 2003; 192: 89-95
5. Senju O, Takagi Y, Uzawa R, Iwasaki Y, Suzuki T, Gomi K, Ishii T, A new immuno quantitative method by latex agglutination - application for the determination of serum C-reactive protein (CRP) and its clinical significance. J Clin Lab Immunol 1986; 19: 99-103
6. Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med 1992; 37: 313-336
7. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci 1982; 389: 406-418
8. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Miyazawa Y, Shihratori T, Hayashi H, Aoki T, Sugaya M, Gunji Y, Kobayashi S, Ochiai T. Prognostic value of preoperative serum immunosuppressive acidic protein in patients with esophageal squamous cell carcinoma. Dis Esophagus 2003; 16: 102-106
9. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179-1186
10. Gelin J, Moldawer LL, Lonnroth C, Sherry B, Chizzonite R, Lundholm K. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 1991; 51: 415-421
11. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989; 250: 607-610
12. Cooper EH, Stone J. Acute phase reactant proteins in cancer. Adv Cancer Res 1979; 30: 1-44
13. Gurleyik E, Gurleyik G, Unalmiser S. Accuracy of serum C-reactive protein measurements in diagnosis of acute appendicitis compared with surgeon's clinical impression. Dis Colon Rectum 1995; 38: 1270-1274
14. Ferguson MK, Martin TR, Reeder LB, Olak J. Mortality after esophagectomy: risk factor analysis. World J Surg 1997; 21: 599-603; discussion 603-604
15. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001; 233: 338-344
16. Fagevik Olsen M, Wennberg E, Johnsson E, Josefson K, Lonroth H, Lundell L. Randomized clinical study of the prevention of pulmonary complications after thoracoabdominal resection by two different breathing techniques. Br J Surg 2002; 89: 1228-1234
17. Fan ST, Lau WY, Yip WC, Poon GP, Yeung C, Lam WK, Wong KK. Prediction of postoperative pulmonary complications in oesophagogastric cancer surgery. Br J Surg 1987; 74: 408-410
18. Law SY, Fok M, Wong J. Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg 1994; 18: 339-346
19. Lund O, Kimose HH, Aagaard MT, Hasenkam JM, Erlandsen M. Risk stratification and long-term results after surgical treatment of carcinomas of the thoracic esophagus and cardia. A 25-year retrospective study. J Thorac Cardiovasc Surg 1990; 99: 200-209
20. Bartels H, Stein HJ, Siewert JR, Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998; 85: 840-844
21. Katsuta T, Saito T, Shigemitsu Y, Kinoshita T, Shiraishi N, Kitano S. Relation between tumour necrosis factor alpha and interleukin 1beta producing capacity of peripheral monocytes and pulmonary complications following oesophagectomy. Br J Surg 1998; 85: 548-553
22. Tsuda T, Tahara E, Kajiyama G, Sakamoto H, Terada M, Sugimura T. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res 1989; 49: 5505-5508
23. Lu SH, Hsieh LL, Lou FC, Weinstein IB. Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer 1988; 42: 502-505
24. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein 113. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 1992; 52: 2980-2983
25. Kobayashi S, Koide Y, Endo M, Isono K, Ochiai T. The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability. Am J Surg 1999; 177: 497-502
26. Gotoda T, Matsumura Y, Kondo H, Ono H, Kanamoto A, Kato H, Watanabe H, Tachimori Y, Nakanishi Y, Kakizoe T. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut 2000; 46: 14-19
27. Uchida S, Shimada Y, Watanabe G, Tanaka H, Shibagaki I, Miyahara T, Ishigami S, Imamura M. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer 1998; 77: 1704-1709
28. Youssef EM, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H, Watanabe T, Katsura Y, Wanibuchi H, Fukushima S. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 1995; 76: 358-366
29. Ikeda M, Natsugoe S, Ueno S, Baba M, Aikou T. Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg 2003, 238: 197-202